ACCELERATED BIOLOGICS DEVELOPMENT
Yeast Technology for Accelerated, Cost-Effective Biologics Development
ABOUT BIOSAVITA
BioSavita's technology platform includes genetically engineered Saccharomyces cerevisiae (S. cerevisiae) yeast strains and
plug-and-play multicopy yeast expression vectors designed for simultaneous production of multiple antigens.
- A privately held biotechnology company
- Patented and proprietary yeast platform technology for cost-effective biologics production
- Senior management team of over 100 years of combined experience in private and publicly traded biotechnology companies
- Multi-billion dollar growth market opportunity
OUR TEAM
BioSavita’s leadership is comprised of senior executives who have successfully launched and led early stage ventures in multiple biotech and pharmaceutical companies along with world-leading scientists and researchers.
Contact Us
BioSavita, Inc
Nalini Motwani, Ph.D., President
Phone: 734-233-3146
Mobile: 248-320-5562
Life Science & Innovation Corridor
46701 Commerce Center Drive
Plymouth, MI 48170
